Efficacy and Safety of Tofacitinib Modified-Release 11 Mg Once Daily Plus Methotrexate in Adult Patients with Rheumatoid Arthritis: 24-Week Open-Label Phase Results from a Phase 3b/4 Methotrexate Withdrawal Non-Inferiority Study (ORAL Shift).
RMD Open（2021）
Key words
arthritis,rheumatoid,Methotrexate,patient reported outcome measures
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined